Rapid Micro Biosystems (RPID) Total Current Liabilities (2020 - 2026)

Rapid Micro Biosystems (RPID) has 7 years of Total Current Liabilities data on file, last reported at $19.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 27.49% year-over-year to $19.1 million; the trailing twelve-month figure through Mar 2026 stood at $19.1 million (up 27.49% YoY), and the FY2025 full-year result was $18.5 million, up 5.25% from the prior year.
• Total Current Liabilities grew to $19.1 million in Q1 2026, from $18.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $19.1 million in Q1 2026 to a low of $12.8 million in Q2 2022.
• A 5-year average of $16.2 million and a median of $15.9 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities decreased 20.34% in 2022 and increased 27.49% in 2026, its largest moves.
• Tracing RPID's Total Current Liabilities over 5 years: stood at $19.0 million in 2022, then decreased by 0.34% to $19.0 million in 2023, then fell by 7.48% to $17.6 million in 2024, then increased by 5.25% to $18.5 million in 2025, then advanced by 3.42% to $19.1 million in 2026.
• Business Quant data shows RPID's Total Current Liabilities at $19.1 million in Q1 2026, $18.5 million in Q4 2025, and $16.5 million in Q3 2025.